FGF23 and metabolic syndrome: Recent studies demonstrate that FGF23 exacerbates left ventricle hypertrophy where αKlotho might not be expressed [89] and elevated plasma FGF23 levels are associated with low body mass index and dyslipidemia in dialysis patients [98].